Sabra Health Care REIT (SBRA) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
13 Feb, 2026Executive summary
SHOP portfolio NOI growth, excluding transition facilities, is expected to remain strong in 2026, with transition assets anticipated to further boost performance as they recover.
Focus on quality care, deep industry experience, and partnering with skilled operators positions the company for long-term value creation in healthcare real estate.
Corporate sustainability initiatives emphasize environmental stewardship, diversity, and governance, with 55% of workforce and 57% of management being women, and 34% of team members identifying as ethnic minorities.
Q4 2025 net income per diluted share was $0.11, FFO $0.36, and AFFO $0.37 per share, with strong occupancy and margin improvements across senior housing and skilled nursing portfolios.
2025 investment activity reached $450 million, with a robust pipeline and $240 million in awarded deals expected to close in early 2026.
Financial highlights
Q4 2025 normalized FFO per share was $0.36 and normalized AFFO per share was $0.38; in absolute terms, $91.2 million and $95.2 million, respectively.
Q4 2025 total revenues were $211.9 million, up from $182.3 million in Q4 2024; full-year 2025 net income was $155.6 million, up from $126.7 million in 2024.
Managed senior housing portfolio cash NOI grew $5.5 million sequentially, while triple-net portfolio cash NOI decreased $1.3 million due to asset transitions.
Sequential revenue growth in the managed senior housing portfolio was 15.8%, with cash NOI up 18.4% and margin expansion of 60 basis points.
Same-store managed senior housing revenue grew 6.4% year-over-year, with Canadian communities up 10%.
Outlook and guidance
2026 guidance: Net income per share $0.60–$0.64, FFO $1.49–$1.53, AFFO $1.55–$1.59; midpoint implies ~5% growth over 2025.
Guidance assumes no uncompleted 2026 investments, dispositions, or capital markets activities.
Triple-net portfolio cash NOI growth expected to be low single-digit, while same-store managed senior housing cash NOI growth is projected in the low-to-mid-teens.
General and administrative expense expected at $52 million, including $12 million stock-based compensation; cash interest expense at $103 million.
Management expects to exceed 2025’s investment total, with $240 million in awarded investments expected to close in early 2026.
Latest events from Sabra Health Care REIT
- 2024 guidance raised as managed senior housing and FFO/AFFO growth accelerate.SBRA
Q2 20242 Feb 2026 - Q3 2024 saw strong earnings, raised guidance, and robust liquidity amid sector growth.SBRA
Q3 202417 Jan 2026 - 2024 saw strong AFFO growth and margins, with 2025 guidance projecting further FFO gains.SBRA
Q4 20248 Dec 2025 - Director elections, auditor ratification, and executive pay highlight strong governance and ESG.SBRA
Proxy Filing2 Dec 2025 - Annual meeting to vote on directors, executive pay, and auditor ratification, all board-backed.SBRA
Proxy Filing2 Dec 2025 - Q2 2025 saw higher earnings, strong senior housing growth, and raised 2025 guidance.SBRA
Q2 202523 Nov 2025 - Q1 2025 delivered higher earnings, strong FFO, and robust liquidity with major deals pending.SBRA
Q1 202519 Nov 2025 - Q3 2025 delivered strong managed senior housing growth, acquisitions, and a Moody's upgrade.SBRA
Q3 202513 Nov 2025